# ![@cafepharma Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::15974185.png) @cafepharma cafepharma

cafepharma posts on X about novartis, $abbv, sanofi, ipo the most. They currently have [------] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

### Engagements: [---] [#](/creator/twitter::15974185/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::15974185/c:line/m:interactions.svg)

- [--] Week [-----] +21%
- [--] Month [-----] +52%
- [--] Months [------] +51%
- [--] Year [------] +35%

### Mentions: [--] [#](/creator/twitter::15974185/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::15974185/c:line/m:posts_active.svg)

- [--] Month [--] -50%
- [--] Months [--] +39%
- [--] Year [---] +34%

### Followers: [------] [#](/creator/twitter::15974185/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::15974185/c:line/m:followers.svg)

- [--] Week [------] -0.05%
- [--] Month [------] -0.13%
- [--] Months [------] -0.52%
- [--] Year [------] -1.60%

### CreatorRank: [---------] [#](/creator/twitter::15974185/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::15974185/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  [finance](/list/finance)  [countries](/list/countries)  [technology brands](/list/technology-brands)  [vc firms](/list/vc-firms)  [us election](/list/us-election)  [travel destinations](/list/travel-destinations)  [exchanges](/list/exchanges)  [nfl](/list/nfl)  [cryptocurrencies](/list/cryptocurrencies) 

**Social topic influence**
[novartis](/topic/novartis) #41, [$abbv](/topic/$abbv), [sanofi](/topic/sanofi), [ipo](/topic/ipo), [china](/topic/china), [novo](/topic/novo), [mon](/topic/mon), [rfk](/topic/rfk), [ai](/topic/ai), [tariffs](/topic/tariffs)

**Top assets mentioned**
[Novartis AG (NVS)](/topic/novartis) [AbbVie Inc (ABBV)](/topic/$abbv) [Sanofi (SNY)](/topic/sanofi) [Pfizer, Inc. (PFE)](/topic/pfizer) [Medtronic PLC (MDT)](/topic/medtronic) [Eli Lilly and Company (LLY)](/topic/eli-lilly) [CVS Health Corp (CVS)](/topic/cvs) [GE HealthCare Technologies Inc. Common Stock (GEHC)](/topic/ge-healthcare) [Merck & Co., Inc. (MRK)](/topic/merck)
### Top Social Posts
Top posts by engagements in the last [--] hours

"Wed news: Novo shares tumble as CEO warns. Earnings from GSK Lilly and more. Novartis sticks with M&A strategy. Amgen resists pulling Tavneos from market. Medtronic to acquire CathWorks. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/anyuser/status/2019090151956222288)  2026-02-04T16:46Z 17.5K followers, [---] engagements


"Mon news: Lilly buys Orna to enter CAR-T arena. Takeda-Iambic AI partnership. Novartis building research facility in San Diego. New Roche MS data. BD slides despite earnings beat. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/anyuser/status/2020910746427691173)  2026-02-09T17:20Z 17.5K followers, [---] engagements


"Thurs news: Sanofi ousts CEO Paul Hudson. Oral Wegovy bringing in 1000s of new patients. IRA boosts Medicare drug coverage. Zimmer to reorganize US salesforce. AbbVie sues over Botox inclusion in IRA. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/anyuser/status/2021991290926510429)  2026-02-12T16:54Z 17.5K followers, [---] engagements


"Fri news: All eyes on Vertex kidney franchise. Novo plans Wegovy vials. Lundbeck migraine trial success. Lilly prepares $1b+ orforglipron stock ahead of approval. Baxter dives on Q4 miss. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/anyuser/status/2022360415762812995)  2026-02-13T17:21Z 17.5K followers, [---] engagements


"Analyst Debate: Is Arena Pharmaceuticals a Top Stock: Motley Fool Sat 12/08/12 - 11:01 am http://t.co/zpID0ujs http://dlvr.it/2c11l5 http://dlvr.it/2c11l5"  
[X Link](https://x.com/cafepharma/status/277454332239167488)  2012-12-08T16:47Z 17.5K followers, [--] engagements


"SillaJen Transgene fall with latest oncolytic virus setback http://dlvr.it/R9cbZt http://dlvr.it/R9cbZt"  
[X Link](https://x.com/cafepharma/status/1157722584428888064)  2019-08-03T18:39Z 17.5K followers, [--] engagements


"Adagio pledges to press forward with COVID drug as CEO to resign http://dlvr.it/SKVSwD http://dlvr.it/SKVSwD"  
[X Link](https://x.com/cafepharma/status/1496441343685513216)  2022-02-23T11:06Z 17.5K followers, [--] engagements


"Thurs news: Novo will take legal action against Hims Wegovy pill copycat. Astellas tops expectations. BMS posts modest growth. JNJ corrects Impella heart pump issue. Biotech IPOs surging. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/anyuser/status/2019463145077551496)  2026-02-05T17:28Z 17.5K followers, [---] engagements


"Eli Lilly buys itself an antibody R&D platform from Tillman Gerngrosss Adimab: Endpoints http://dlvr.it/PWpGfw http://dlvr.it/PWpGfw"  
[X Link](https://x.com/cafepharma/status/887694546691252224)  2017-07-19T15:24Z 17.5K followers, [--] engagements


"Versant partners gear up for a $700M bonanza of biotech bets with a special focus all their own: In a global biotech industry where venture investors carve own familiar strategy Versant Ventures has always preferred to go its own way. Versant partners http://dlvr.it/Qtnxqn http://dlvr.it/Qtnxqn"  
[X Link](https://x.com/cafepharma/status/1074702027043700738)  2018-12-17T16:25Z 17.5K followers, [--] engagements


"Moderna's gene therapy expansion speeds up w/$76M Generation Bio collab- Disgraced former Seagen CEO to lead MorphImmune less than a year after domestic assault arrest- Sanofi & Regeneron's Dupixent scores trial win in COPD -- more on our front page news http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1638933202881376256)  2023-03-23T15:58Z 17.5K followers, [---] engagements


"Eli Lilly to buy Sigilon Therapeutics to expand diabetes treatments Former J&J sales rep indicted on charges of defrauding hospital --Sanofi says it's back to the drawing board on mRNA flu vaccines -- See more on our front page news http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1674449181480550401)  2023-06-29T16:06Z 17.5K followers, [---] engagements


"Biogen to eliminate [----] jobs in further cost cuts -- Cognizant Gilead extend service agreement worth $800M -- Astellas notches another protein degrader pact with $21M upfront for PeptiDream -- See more on our front page news http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1683873001689825280)  2023-07-25T16:13Z 17.5K followers, [---] engagements


"Wed news: [----] Medicare drug price negotiations. BioAge Labs aiming at $180M IPO. Merck Keytruda colorectal cancer flop. Sanofi gets bids for consumer health unit. Novo Nordisk CEO in Senate hot seat. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1838977558865469832)  2024-09-25T16:23Z 17.5K followers, [---] engagements


"Mon news: Lilly cuts Zepbound prices again for DTC. Novo uses FDA voucher for speedy review of high dose Wegovy. Zero tariff pharma deal for US and UK. Regeneron makes $275M gene editing play. CMS to cover cardiac ablation in ambulatory surgery centers. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1995538329589239845)  2025-12-01T16:59Z 17.5K followers, [---] engagements


"Wed news: JPMHC: AZs $80B revenue target within reach. AbbVie Amgen Lilly lead calls for updated post-approval change rules. JPMHC: Biotech IPO sector poised to rebound. Travere hammered on surprise FDA delay. Boston Sci gets new PFA catheter approval. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/2011485830917783718)  2026-01-14T17:09Z 17.5K followers, [---] engagements


"Thurs news: Roche and Sanofi earnings fail to excite. AZ vows China investment. Medtech M&A took off in second half of [----]. Tenpoint looks to launch presbyopia eyedrops after FDA nod. Hair loss biotech IPO. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/anyuser/status/2016916347708416397)  2026-01-29T16:48Z 17.5K followers, [---] engagements


"Roche Acquires MS Remyelination Program from Versant Ventures: CP Wire http://dlvr.it/QNPy5X http://dlvr.it/QNPy5X"  
[X Link](https://x.com/cafepharma/status/981540641401286657)  2018-04-04T14:34Z 17.5K followers, [--] engagements


"New Versant Ventures startup goes gutless for next-generation gene delivery http://dlvr.it/SWP2Np http://dlvr.it/SWP2Np"  
[X Link](https://x.com/cafepharma/status/1557379756185645058)  2022-08-10T14:54Z 17.5K followers, [--] engagements


"Novo Nordisk to acquire Forma Therapeutics in $1.1. bln deal http://dlvr.it/SXcJ2K http://dlvr.it/SXcJ2K"  
[X Link](https://x.com/cafepharma/status/1565366267254820864)  2022-09-01T15:49Z 17.5K followers, [--] engagements


"Biopharma Layoff Tracker 2023: Rain Oncology Takeda PTC and more cut staff Merck study: mRNA technology a game changer for Asia-Pacific vaccine manufacturers --Key FDA decisions on the horizon -- See more on our front page news http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1663935771772952577)  2023-05-31T15:49Z 17.5K followers, [---] engagements


"Lilly makes bet on IL-17 with $2.4B acquisition of Dice Therapeutics AstraZeneca drops another GLP-1 after phase [--] data bust diabetes hopes -- FDA places clinical hold on Arcellxs multiple myeloma therapy trial -- See more on our front page news http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1671182470853566466)  2023-06-20T15:45Z 17.5K followers, [---] engagements


"Bayer christens $250M cell therapy 'launch facility' in Berkeley - Merck's Keytruda hits overall survival goal in early lung cancer as FDA decision nears - Ventyx Biosciences reports data from ulcerative colitis drug trial - See more on our front page news http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1711781540047298861)  2023-10-10T16:31Z 17.5K followers, [---] engagements


"J&J scoops up cardio medtech Shockwave Medical for $13.1BFDA allows expanded use of Bristol Myers' cell therapy for blood cancerBoehringer to lay off salespeople as Humira biosimilar sales lag-- for more: http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1776280058467901733)  2024-04-05T16:05Z 17.5K followers, [---] engagements


"Eli Lillys growth drivers Verzenio and Jardiance suffer clinical setbacksPrime editing comes of age as FDA clears human trials Novartis pays PeptiDream $180M as radiopharma big bang continues-- more news: http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1785330471515119634)  2024-04-30T15:28Z 17.5K followers, [---] engagements


"Thurs news: FDA misses Novavax vaccine review deadline. RFK Jr. ends public comment for HHS policies. FTC halts case against PBMs. Biotech megarounds hold steady. BeiGene abandons TIGIT drug. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1907820289423032536)  2025-04-03T15:39Z 17.5K followers, [---] engagements


"Thurs news: BMS and Pfizer to offer Eliquis DTC. GSK prefilled shingles vaccine approved. CDER employees leaving FDA in droves. Abbott Labs has rare guidance miss. [---] Sarepta layoffs. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1945874561737650245)  2025-07-17T15:53Z 17.5K followers, [---] engagements


"Wed news: JNJ earnings. Pfizer CEO lays blame on RFK Jr. Astellas banner year. Roche raises NC manufacturing investment. GSK licenses Alteogen enzyme. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/anyuser/status/2014028342266089909)  2026-01-21T17:32Z 17.5K followers, [---] engagements


"Mon news: Biopharma layoffs - whats ahead for [----]. AZ keeps pause on UK R&D site. Express Scripts considering settlement with FTC. Intuitive pushes into cardiac robotic surgery. Merck no longer buying Revolution Medicines. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/anyuser/status/2015831116742082799)  2026-01-26T16:56Z 17.5K followers, [---] engagements


"Fri news: AZ leans into obesity with China alliance. Amgen jilts Kyowa Kirin. Moderna offloads rare disease drug. Top medtech trends for [----]. Takeda lifts guidance. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/anyuser/status/2017286802332135525)  2026-01-30T17:20Z 17.5K followers, [---] engagements


"Mon news: Obesity market sales potential tightens. Sanofis troubled GCS inhibitor. FDA launches PreCheck program. GSK walks away from Wave RNA editing drug. Roches return to RNA continues. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/anyuser/status/2018362488828375401)  2026-02-02T16:34Z 17.5K followers, [---] engagements


"Tue news: Pfizers Metsera GLP-1 bet generating weight loss in phase 2b. BMS and JNJ want to educate HCPs before milvexian data drop. PBMs hit by Trump rule. Merck tops Q4 estimates. Novos combo obesity shot meets trial goal. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/anyuser/status/2018722461391479080)  2026-02-03T16:25Z 17.5K followers, [---] engagements


"CAMP4 Therapeutics Receives $30 Million Series A to Continue Developing Unique Discovery Platform: CAMP4 Therapeutics is on a mission to modernize the way the pharma industry discovers new treatments. Operating at the intersection of biology and http://dlvr.it/QVkH3K http://dlvr.it/QVkH3K"  
[X Link](https://x.com/cafepharma/status/1002183496809381888)  2018-05-31T13:42Z 17.5K followers, [--] engagements


"Takeda shareholders bin proposal from anti-Shire group; only [--] percent in favor: A group of Takeda Pharmaceutical Co Ltd (4502.T) shareholders who are trying to build support to block the $62 billion acquisition of London-listed Shire Plc (SHP.L) http://dlvr.it/QYw2XL http://dlvr.it/QYw2XL"  
[X Link](https://x.com/cafepharma/status/1012652671017205760)  2018-06-29T11:03Z 17.5K followers, [--] engagements


"Taisho Nears $1.6 Billion Deal for Bristol-Myers Unit: Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd (4581.T) is said to be close to a $1.6 billion deal for Bristol-Myers Squibb Co's (BMY.N) French over-the-counter drugs business UPSA http://dlvr.it/QtnLgM http://dlvr.it/QtnLgM"  
[X Link](https://x.com/cafepharma/status/1074660750847688704)  2018-12-17T13:41Z 17.5K followers, [--] engagements


"Turn Therapeutics Announces Positive In-Vivo Data for Non-Melanoma Skin Cancer Candidate http://dlvr.it/STqdZh http://dlvr.it/STqdZh"  
[X Link](https://x.com/cafepharma/status/1547232903041392642)  2022-07-13T14:54Z 17.5K followers, [--] engagements


"In label expansion bid AbbVie and Roche's Venclexta falls short in multiple myeloma-- Teva continues its transformation hiring Christine Fox to take over US biz -- Adlai Nortye IPO gives old Novartis cancer drug new life - See more on our front page news http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1707795198011494734)  2023-09-29T16:31Z 17.5K followers, [---] engagements


"Gilead bets on Xilio cancer drug as biotech restructuresSanders blasts Novo Nordisk for outrageous price of Ozempic WegovyBoundless Bio breaks IPO lull with $100M fundraise-- for more news: http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1773380950040166730)  2024-03-28T16:05Z 17.5K followers, [---] engagements


"Thu news: JNJ autoimmune drug approval. More Keytruda trial failures. Pharma digital disconnect. Cognition Therapeutics Alzheimers med. GSK RSV vax gets EU ok. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1829182863218225495)  2024-08-29T15:42Z 17.5K followers, [---] engagements


"Mon news: Lilly at ASH- makes case to widen Jaypirca use. Structure Therapeutics soars on obesity asset success. Viatris to sell stake in Biocon Biologics. Regeneron at ASH - Lynozyfic in myeloma. Waves promising weight loss trial. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1998072983911563449)  2025-12-08T16:51Z 17.5K followers, [---] engagements


"Wed news: Lillys prospective CV launches dominate Clarivate list. [--] drug approvals to watch in [----]. Lilly might be looking to buy Ventyx Bio. GSK hep B treatment proves worth in phase [--]. Amgen-Disco $618M cancer pact. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/2008949793457099188)  2026-01-07T17:12Z 17.5K followers, [---] engagements


"Thurs news: Boston Sci buying Penumbra for $14.5B. JPMHC: Astellas CEO talks Xtandi patent cliff. Lilly Sanofi among delayed FDA priority reviews. FDA/EMA collab on AI drug development guidelines. JNJs case for earlier Tecvayli multiple myeloma use https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/2011846704685895954)  2026-01-15T17:03Z 17.5K followers, [---] engagements


"Fri news: Novos new Wegovy pill shows solid launch data. JPMHC takeaways. Legal questions swirl around new FDA priority review program. Sanofi rumored to be bidding to takeover Ocular Therapeutix. Trumps new healthcare proposal and drugmakers. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/2012211555903942988)  2026-01-16T17:13Z 17.5K followers, [---] engagements


"Tue news: AstraZeneca continues earnings ambitions. Novo patent suit over Hims Wegovy copy. Stryker releases handheld knee robot. CVS profits hit nearly $3B. FDA calls out Novo TV ad as false or misleading. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/anyuser/status/2021266773333463512)  2026-02-10T16:55Z 17.5K followers, [---] engagements


"Takeda makes $61 billion bid for drugmaker Shire: sources: Takeda Pharmaceutical (4502.T) has made a bid for Shire (SHP.L) that values the London-listed drugmaker at around $61 billion two sources with direct knowledge of the matter told Reuters. http://dlvr.it/QQ4WtP http://dlvr.it/QQ4WtP"  
[X Link](https://x.com/cafepharma/status/986963366005506048)  2018-04-19T13:42Z 17.5K followers, [--] engagements


"FDA panel to discuss Celltrion biosimilar: FDA's Oncologic Drugs Advisory Committee will meet on Oct. [--] to review a resubmitted BLA for CT-P10 from Celltrion Inc. (KOSDAQ:068270) the company's biosimilar of Rituxan/MabThera rituximab. http://dlvr.it/Qjx88h http://dlvr.it/Qjx88h"  
[X Link](https://x.com/cafepharma/status/1039831762111590400)  2018-09-12T11:03Z 17.6K followers, [--] engagements


"Genmab and Johnson & Johnsons Darzalex Dazzles in Multiple Myeloma Trial: Denmark-basedGenmab A/Sreleasedtopline data from its Phase III MAIA trial of a drug it licensed toJohnson & JohnsonsJanssen Darzalex (daratumumab). The drug is being http://dlvr.it/Qq0Fxs http://dlvr.it/Qq0Fxs"  
[X Link](https://x.com/cafepharma/status/1057317478223630337)  2018-10-30T17:05Z 17.5K followers, [--] engagements


"FDA approves first biosimilar for NHL: FDA approved a resubmitted BLA for Truxima rituximab-abbs from Celltrion Inc. (KRX:068270) and Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA). The agency said Truxima is the first biosimilar approved http://dlvr.it/QsP6dx http://dlvr.it/QsP6dx"  
[X Link](https://x.com/cafepharma/status/1068121029405360128)  2018-11-29T12:34Z 17.6K followers, [--] engagements


"FDA approves Celltrion's Herceptin biosimilar: FDA approved a BLA for Herceptin biosimilar Herzuma trastuzumab-pkrb from Celltrion Inc. (KOSDAQ:068270) to treat HER2-positive breast cancer. http://dlvr.it/Qtjz2Q http://dlvr.it/Qtjz2Q"  
[X Link](https://x.com/cafepharma/status/1074289811907698688)  2018-12-16T13:07Z 17.6K followers, [--] engagements


"Shockwave Medical Plans IPO: Shockwave Medical filed for its IPO on 2/8/19. While the filing did not list the number of shares to be offered or the expected offering price the offering will bring in an expected maximum of $70 million. http://dlvr.it/QyflmH http://dlvr.it/QyflmH"  
[X Link](https://x.com/cafepharma/status/1094988192120418306)  2019-02-11T15:55Z 17.5K followers, [--] engagements


"3SBio gains Verseau's macrophage checkpoint modulators for cancer: With a deal to license macrophage checkpoint modulators 3SBio Inc. (HKSE:1530) is bypassing the standard roster of T cell targets and jumping to the next wave of immuno-oncology targets. http://dlvr.it/QykbYW http://dlvr.it/QykbYW"  
[X Link](https://x.com/cafepharma/status/1095333465707302918)  2019-02-12T14:47Z 17.6K followers, [--] engagements


"Sorrento and Yuhan Secure $40 Million for Immuno-Oncology Joint Venture: Yuhan Corporation (000100.KS; Yuhan) and Sorrento Therapeutics (Nasdaq: SRNE) announced on 2/12/19 that ImmuneOncia a joint venture formed in September [----] has completed a http://dlvr.it/QykrYL http://dlvr.it/QykrYL"  
[X Link](https://x.com/cafepharma/status/1095349951880515584)  2019-02-12T15:52Z 17.5K followers, [--] engagements


"The Bristol-MyersSquibb Deal May No Longer Be a Sure Thing but It Will Still Likely Happen: The deal between Bristol-Myers Squibb (BMY) and Celgene (CELG) has been garnering plenty of headlines this week and no matter what happens there are likely to http://dlvr.it/R02BSW http://dlvr.it/R02BSW"  
[X Link](https://x.com/cafepharma/status/1101906650808475649)  2019-03-02T18:06Z 17.5K followers, [--] engagements


"Sillajen explains Pexa-Vec trial failure it was the rescue meds http://dlvr.it/R9mXYZ http://dlvr.it/R9mXYZ"  
[X Link](https://x.com/cafepharma/status/1158759670703480832)  2019-08-06T15:20Z 17.6K followers, [--] engagements


"SK Biopharmaceuticals fresh off an FDA nod preps for $850M IPO in January: report http://dlvr.it/RK5lMQ http://dlvr.it/RK5lMQ"  
[X Link](https://x.com/cafepharma/status/1199161488641912833)  2019-11-26T03:02Z 17.5K followers, [--] engagements


"SK Biopharmaceuticals IPO Tabbed to Raise $850 Million http://dlvr.it/RKbG5z http://dlvr.it/RKbG5z"  
[X Link](https://x.com/cafepharma/status/1201886949159518209)  2019-12-03T15:32Z 17.5K followers, [--] engagements


"Verastem pens KRAS-focused drug licensing deal with Chugai http://dlvr.it/RMg0RW http://dlvr.it/RMg0RW"  
[X Link](https://x.com/cafepharma/status/1214936435825901569)  2020-01-08T15:46Z 17.5K followers, [--] engagements


"SK Biopharmaceuticals emerges from pandemic delays with pitch for $822M IPO http://dlvr.it/RYgpYl http://dlvr.it/RYgpYl"  
[X Link](https://x.com/cafepharma/status/1272558369753067520)  2020-06-15T15:55Z 17.6K followers, [--] engagements


"FDA approves PharmaEssentia interferon drug for a rare type of blood cancer http://dlvr.it/SCbKsc http://dlvr.it/SCbKsc"  
[X Link](https://x.com/cafepharma/status/1460560421660684290)  2021-11-16T10:48Z 17.6K followers, [--] engagements


"With $415M on the line Genmab taps Synaffix for antibody-drug conjugate technologies http://dlvr.it/SGWXFX http://dlvr.it/SGWXFX"  
[X Link](https://x.com/cafepharma/status/1478403113694334976)  2022-01-04T16:29Z 17.5K followers, [--] engagements


"Novartis' Sandoz reportedly the target of $25B buyout bid from Carlyle and Blackstone http://dlvr.it/SJDz3Q http://dlvr.it/SJDz3Q"  
[X Link](https://x.com/cafepharma/status/1488826546852818946)  2022-02-02T10:48Z 17.5K followers, [--] engagements


"No news anytime soon on Sandoz sale says Novartis http://dlvr.it/SJKMFJ http://dlvr.it/SJKMFJ"  
[X Link](https://x.com/cafepharma/status/1489265443156086792)  2022-02-03T15:52Z 17.6K followers, [--] engagements


"Novartis eyes next-gen AAV gene therapies in $1.75B Voyager biobucks pact http://dlvr.it/SLJn5T http://dlvr.it/SLJn5T"  
[X Link](https://x.com/cafepharma/status/1501224609017786369)  2022-03-08T15:53Z 17.6K followers, [--] engagements


"BioNTech buys UK AI start-up InstaDeep in 562mn deal JPM23: Gilead Takeda Pfizer Moderna and more The Big Three PBMs [----] formulary exclusions: observations on insulin Humira and biosimilars -- See more on our front page news http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1612857073028431872)  2023-01-10T17:01Z 17.6K followers, [---] engagements


"Most-clicked news items for the weekend ending 3-18-23: #Medtronic #medtech #inflation #drugpricing #Pfizer #Novartis #Merck #bristolmyerssquibb #lungcancer #JNJ #executivecompensation https://bit.ly/3n15DSW https://bit.ly/3n15DSW"  
[X Link](https://x.com/cafepharma/status/1637524648660287488)  2023-03-19T18:41Z 17.6K followers, [---] engagements


"Most-clicked pharma news for week ending April [--] 2023: Signify Health acquisition Ferring Research Institute shutdown Jardiance sales increase and more CP Wire https://bit.ly/433b8kn https://bit.ly/433b8kn"  
[X Link](https://x.com/cafepharma/status/1642997585223745541)  2023-04-03T21:08Z 17.5K followers, [---] engagements


"Amgen-Horizon merger clearance a setback to FTC's antirust enforcement plans -- Genentech sees more potential in peptides signs $1B biobucks deal with PeptiDream -- FDA rejects nasal spray for severe allergic reactions -- See more on our front page news http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1704531491542208957)  2023-09-20T16:22Z 17.5K followers, [---] engagements


"GSK outpaces Pfizer in RSV vaccine market-- Why the next blockbuster therapy may come out of Singapore --AstraZeneca drops $245M on cell and gene therapies in deal with Cellectis -- See more on our front page news http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1719739325649150168)  2023-11-01T15:33Z 17.6K followers, [---] engagements


"AstraZeneca scoops up Fusion Pharmaceuticals in $2.4B radiopharma dealIn his final full year as AbbVie's CEO Richard Gonzalez collects $25.7M in total payBayer cues up filings for rival to Astellas menopause drug--more news here: http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1770119599796666676)  2024-03-19T16:06Z 17.5K followers, [---] engagements


"Fri news: Iterums UTI drug. Edwards layoffs. Zenas BioPharma IPO. GSKs Nucala hits COPD target. Pharma layoff stories. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1832086753437684134)  2024-09-06T16:01Z 17.5K followers, [---] engagements


"Thurs news: AZ deepens China presence with FibroGen deal. BMS Opdivo win in preoperative NSCLC. Insurers push back on GLP-1 coverage. Hims & Hers to offer at-home blood tests. Novartis and Roche CEO pay raises. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1892620414506906032)  2025-02-20T17:00Z 17.8K followers, [---] engagements


"Fri news: Teva launches Stelara biosimilar. Device industry anticipates delays. Ozempic shortage resolved. CDC vaccine meeting postponed. Bluebird Bio agrees to take-private deal. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1892978254845297001)  2025-02-21T16:42Z 17.8K followers, [---] engagements


"Wed news: Jazz buying Chimerix for cancer drug. Kenvues fight with activist Starboard. Novo offers direct access channel for Wegovy. Amgen refocusing business strategy. DOGE to cancel [--] FDA leases. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1897334505180201407)  2025-03-05T17:12Z 17.5K followers, [---] engagements


"Wed news: Bluebird Bio sticks with private equity. CDC advisors consider RSV vax for younger ages. Abbott maintains profit forecast. Is Raleigh the next pharma manufacturing hub Trumps exec order to lower drug prices. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1912536363947163914)  2025-04-16T15:59Z 17.5K followers, [---] engagements


"Tue news: TGSK axes $625M TIGIT drug. Elizabeth Holmes partner raising $$ for blood-testing startup. Bluebird Bios potential bankruptcy. HIV market expected to reach $32.1B by [----]. GOPs transparent PBM pricing model. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1922314393972351029)  2025-05-13T15:34Z 17.5K followers, [---] engagements


"Thurs news: Summit in talks with AZ about Keytruda rival. Intuitive Surgicals da Vinci [--] wins CE Mark. Novartis trial fail. RFK Jr and the wearables market. Bluebird Bio going private and what is signals. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1940804451469873177)  2025-07-03T16:06Z 17.5K followers, [---] engagements


"Tue news: China biotechs reshaping US biopharma. GSK eyes Blenreps US return. Quest to offer Alzheimers test. Kenvue CEO departure. Wojcicki wins back 23andMe. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1945148920633446814)  2025-07-15T15:50Z 17.5K followers, [---] engagements


"Tue news: Sanofi buying UK biotech. Replimmune plummets on melanoma rejection. Novartis Zolgensma sales fall. Quest Diagnostics Q2 beat. Sarepta stops Elevidys shipments. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1947687043636539787)  2025-07-22T15:55Z 17.5K followers, [---] engagements


"Tue news: Obesity leaders dig manufacturing moats. Another phase [--] win for Novartis drug. Cardinal Health buying Solaris. Pfizer-Astellas bladder cancer drug trial success. AI and biotech bill package. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1955303336946639014)  2025-08-12T16:20Z 17.5K followers, [---] engagements


"Tue news: Lilly weight loss pill clears latest trial. Terumo buying OrganOx. Will COVID vaccines be banned Roche US manufacturing facility. MannKind grabs scPharmaceuticals. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1960367859483263132)  2025-08-26T15:44Z 17.6K followers, [---] engagements


"Tue news: Arrowhead-Novartis siRNA collaboration. Medtech VC funding highest since [----]. Ionis shares jump on triglyceride trial. Merck oral cholesterol pill meets phase [--] trial goal. Eisai-Biogen get at-home dosing approval for Leqembi http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1962909470847090837)  2025-09-02T16:04Z 17.6K followers, [---] engagements


"Fri news: FDA looks to abandon expert reviews. Novartis IRA price negotiation fail. GE HealthCare buying brain imaging firm. Maze soars on early molecules potential. AbbVie will have Rinvoq shielded from generics until [----]. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1966533795923853561)  2025-09-12T16:06Z 17.6K followers, [---] engagements


"Fri news: GE Healthcare may sell China unit. CDC vaccine comm delays vote on hep B vaccine. JNJs promising multiple myeloma trial results. Novo cuts diabetes education team. Bluebird bio rebranding. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1969075157047103617)  2025-09-19T16:24Z 17.5K followers, [---] engagements


"Mon news: Pfizers $4.9B Mesera buyout for obesity pipeline. Novartis looks to bring down US drug costs. Medtronic urinary incontinence device. Whos leading the AI drug discovery race Mercks subcutaneous Keytruda approved. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1970155689709588545)  2025-09-22T15:58Z 17.6K followers, [---] engagements


"Tue news: Roches obesity pipeline. Tylenol-maker Kenvue shares bounce back. Mercks AI deal. Scholar Rock manufacturing issues. FDA turns down Lundbeck Otsuka's Rexulti in PTSD. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1970525687900708967)  2025-09-23T16:28Z 17.5K followers, [---] engagements


"Mon news: GSK CEO Walmsley stepping down - AZ plans NYSE listing. Gilead to pump up virology pipeline. Genmab buying Merus. Exemptions possible for pharma tariffs. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1972690384623927510)  2025-09-29T15:50Z 17.6K followers, [---] engagements


"Fri news: FDA to fast-track domestically made generics. GSK overturns UK watchdog sanction. Who will be the remaining top women pharma CEOs Cidaras $339m BARDA award. Jazz/Roche lung cancer combo approval. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1974173021683478837)  2025-10-03T18:01Z 17.6K followers, [---] engagements


"Mon news: Amgen unveils DTC platform with 60% Repatha discount. Delayed triple negative readout for AZ-Daiichi. AstraZeneca pens AI pac with Algen. Skye obesity drug crashes. Q3 biopharma layoffs hold steady. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1975245416846209446)  2025-10-06T17:03Z 17.6K followers, [---] engagements


"Thurs news: Novo to buy Akero for up to $5.2B. UK and US agencies team up for medtech-AI regulation. Key vaccine panel meeting delayed. Regenerons Libtayo gains skin cancer label expansion. China accounts for 1/5 of global drugs in development. http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1976319285392715934)  2025-10-09T16:10Z 17.6K followers, [---] engagements


"Fri news: Novo and Lilly stocks drop on Trump promise. Sanofi gets mixed results from Europes CHMP. Astellas walks away from gene therapy pact. FDA awards [--] new national priority drug review vouchers. California to sell its own insulin. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1979239503005962420)  2025-10-17T17:34Z 17.6K followers, [---] engagements


"Mon news: Merck to pour over $70B into US expansion. Rumors that Lilly will buy Nektar. AZ Gilead Roche Amgen Merck Novartis news & more from ESMO. ura to pursue FDA clearance of bp feature. Creative Biolabs expands its bispecific platform. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1980302261264977956)  2025-10-20T15:57Z 17.6K followers, [---] engagements


"Tue news: Almost entire Novo Nordisk board resigns. 3/4 of consumers are interested in DTC sales. Walmart to sell Abbott Lingo CGM. GSK to file oral drug for cUTIs. Galapagos exits cell therapy. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1980670575799320582)  2025-10-21T16:20Z 17.6K followers, [---] engagements


"The Novo Nordisk message board has been our top-traffic board for weeks now and todays mass boardroom shakeup has only made for further activity: https://cafepharma.com/boards/forums/novo-nordisk.100/#gsc.tab=0 https://cafepharma.com/boards/forums/novo-nordisk.100/#gsc.tab=0"  
[X Link](https://x.com/cafepharma/status/1980673627574903114)  2025-10-21T16:32Z 17.6K followers, [---] engagements


"Wed news: Takeda in huge biobucks+$1.2B deal with Innovent. How Novos board bust-up will sharpen US focus. US pharma price probe raises threat of new tariffs. Alkermes to enter sleep market with Avadel buy. Intuitive Surgical earnings beat. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1981038008712269945)  2025-10-22T16:40Z 17.5K followers, [---] engagements


"Thurs news: Roche shares fall as new drug sales disappoint. How JNJ kept growing amid Stelara erosion. Mass biotech hub is limping. Moderna CMV vax fails key study. JNJ sponsoring NY Jets. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1981383556757614993)  2025-10-23T15:33Z 17.6K followers, [---] engagements


"Fri news: Lilly buys Adverum for gene therapy. GLP-1 Rx rate relatively flat. Sanofi earnings. Chugai buys 'Asia lag' firm Renalys. Once-withdrawn GSK drug gets FDA approval. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1981756055916106010)  2025-10-24T16:13Z 17.6K followers, [---] engagements


"Mon news: Novartis shares slip on $12B deal to buy Avidity. Innocent/Lillys mazdutide beats Novo in head-to-head. MapLight IPO to fund BMS competitor. Organon CEO resigns amid internal investigation. Intellia plummets on paused trial. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1982841601581019323)  2025-10-27T16:07Z 17.6K followers, [---] engagements


"Tue news: FDA rejects Eylea HD for manufacturing issues. Novartis earnings. Three MS trials to watch. Merck-Eisai kidney cancer combo trial. Texas sues Kenvue over Tylenol autism claim. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1983209561801597185)  2025-10-28T16:29Z 17.5K followers, [---] engagements


"Wed news: GSK earnings. Lilly-Walmart Zepbound access. GE Healthcare revenue growth. What is next for Novo Lilly-Nvidia pharma supercomputer. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1983568675438272912)  2025-10-29T16:16Z 17.6K followers, [---] engagements


"Fri news: Lilly weight loss drug will be candidate for new FDA speedy approval program. Pfizer may hold Trump card in Metsera bid. Gilead ends HIV trial. Merck vaccine sales drop. Biogen-Neurocrine-Alnylam earnings. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1984297357878452314)  2025-10-31T16:32Z 17.6K followers, [---] engagements


"Mon news: Kimberly Clark buying Tylenol owner Kenvue for more than $40B. AZ Lilly Merck commit $120M to Virginia pharma training. Tariffs pricing backroom deals. FDA director's admin leave sparks controversy. Pfizer sues Metsera and Novo. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1985397078126735569)  2025-11-03T17:22Z 17.6K followers, [---] engagements


"Tue news: Pfizer earnings tops estimates. Two new Merck deals. Novo ups bid for Metsera beating Pfizers new bid. Lilly and Novo reportedly nearing US pricing deal. New startup emerges from Doudnas CRISPR lab. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1985755950624493617)  2025-11-04T17:08Z 17.6K followers, [---] engagements


"Wed news: Novos new CEO on earnings. Is Metsera worth the fuss Amgen halts gastric cancer trial. Bravehart Bio launches. Pfizer pipeline cuts. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1986120712067948892)  2025-11-05T17:17Z 17.6K followers, [---] engagements


"Thurs news: AZ quarter revenue hits new height. Lilly amylin agonist heads to phase [--]. Novartis radiopharma success. New indication for JNJs Caplyta. Novartis in Super Bowl [----]. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1986497071608963357)  2025-11-06T18:13Z 17.6K followers, [---] engagements


"Fri news: How weight loss drug price cuts will affect American users. Lillys Mounjaro now top selling drug in India. Gilead breast cancer drug trial fail. FDAs 2nd round of priority vouchers. Intellia shares fall after CRISPR patient dies. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1986851723239944317)  2025-11-07T17:42Z 17.6K followers, [---] engagements


"Every time I see another obesity startup raise $200M I check behind the couch cushions for my own Series A term sheet"  
[X Link](https://x.com/cafepharma/status/1988303459431436779)  2025-11-11T17:51Z 17.6K followers, [---] engagements


"Wed news: Bayer earnings and cancer clear-out. Medtech VC funding slowed in Q3. Alkermes narcolepsy trial. Sandoz expects to enter Ozempic biosims in Canada early [--]. FDA names Pazdur as new CDER director. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1988661837894971634)  2025-11-12T17:35Z 17.6K followers, [---] engagements


"Fri news: Merck buys Cidara and its flu antiviral. Pfizer to divest BioNTech stake. BMS/JNJ blood thinner flunks phase [--]. Lundbeck tries to outbid Alkermes for Avadel. Novo shareholders approve new chair. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1989370841910608102)  2025-11-14T16:32Z 17.6K followers, [---] engagements


"Mon news: JNJ buys Halda for cancer assets. Novo slashing out-of-pocket prices for Ozempic and Wegovy. Lilly bets $2.6B+ for a bispecific antibody platform. BMS and JNJ dump ACS drug milvexian. Labcorp buying Parkview Health outreach lab assets. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1990473443574493673)  2025-11-17T17:33Z 17.6K followers, [---] engagements


"Lilly out here writing $2.6B checks like: If its bispecific and has a preclinical figure with three arrows and a glossy gradient well take it"  
[X Link](https://x.com/cafepharma/status/1990511977194795041)  2025-11-17T20:06Z 17.5K followers, [---] engagements


"Tue news: Merck advances Winrevair in subset of heart failure patients. Vanda tackles Wegovy-driven vomiting. Medtronic lifts forecasts. Scott Gottlieb joins UnitedHealth board. Roche extols breast cancer drug results. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1990831393836863622)  2025-11-18T17:16Z 17.6K followers, [---] engagements


"Wed news: After Lundbeck's surprise bid Alkermes sweetens deal to acquire Avadel. Pfizer wins $41.5M settlement over ADHD drug. Merck HIV therapy matches Gileads. Sackler/Purdue settlement plan gets judge approval. RNAi biotech wins first FDA approval. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1991192097127329943)  2025-11-19T17:09Z 17.6K followers, [---] engagements


"Thurs news: ABT to acquire Exact Sciences for about $21B. Novo GLP-1 Alzheimers study. Regenerons Eyelid HD gets two FDA nods in one day. Modernas $1.5B loan. Madrigals patient-centric MASH strategy. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1991545874884022555)  2025-11-20T16:35Z 17.5K followers, [---] engagements


"Mon news: Novo Alzheimers drug trials fail. Solventum to buy Acera Surgical. JNJ abandons Alzheimers antibody. Biotech CEOs letter to Makary. Bayer blood thinner trial win. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1993000022888349696)  2025-11-24T16:53Z 17.6K followers, [---] engagements


"Tue news: Novo amycretin success in mid-stage diabetes trial. Promising late-stage data for JNJ myeloma combo. Avidity played hardball to land Novartis. More Medicare drug price negotiations. Gileads biobucks TREX1 deal. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1993366715544322398)  2025-11-25T17:10Z 17.6K followers, [---] engagements


"Tue news: Roche is back in Alzheimers. ACIP to discuss childhood vaccine schedule under new chair. Lessons from Novo and JNJs Alzheimers clinical flops. Bayer aims Mirena at new issue. BMS faces $6.7B lawsuit. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1995904455611462009)  2025-12-02T17:14Z 17.5K followers, [---] engagements


"Thurs news: Controversial ACIP meeting starts today. Lilly gets new CLL approval for Jaypirca. JNJ MedTech restructuring. More FDA personnel shifts. Novo gears up for India Ozempic launch. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1996630931239850056)  2025-12-04T17:21Z 17.5K followers, [---] engagements


"Fri news: CDC advisors vote to overturn pediatric hep B vax policy. Eisai confident in anti-tau asset. BMS Breyanzi is first CAR-T for marginal zone lymphoma. Praxis soars on rare childhood epilepsy trial data. CHS sells lab assets to Labcorp. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1996992248861675645)  2025-12-05T17:17Z 17.5K followers, [---] engagements


"Wed news: Roche breast cancer pill cuts recurrence by 30% in trial. FDA launches safety probe of anti-RSV antibodies. Rumors that Lilly may buy Abivax. Daiichi phase [--] Enhertu ovarian cancer trial. Latest on the Biosecure Act. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1998814014756069587)  2025-12-10T17:56Z 17.5K followers, [---] engagements


"Thurs news: Lillys next gen obesity drug delivers strong weight loss + reduced knee pain. Pfizer is not done with M&A. Prolynx gets funding for long lasting obesity drugs. Intuitive wins expanded uses for da Vinci. Will [----] be a breakout year for M&A https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/1999161903260815806)  2025-12-11T16:58Z 17.5K followers, [---] engagements


"Mon news: Sanofi suffers double setback for MS drug. Philips adding AI heart imaging with company purchase. Gilead HIV trial results. Pfizers $890M deal with Adaptive Biotech. BioSecure Act may be finally headed to Trumps desk https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/2000613023929495557)  2025-12-15T17:04Z 17.6K followers, [---] engagements


"Tue news: Pfizer foresees challenging [----]. Genentech and Caris in $1.1B deal for rare cancer targets. Pfizer and Sanofi in separate autoimmune pacts. Makary says no black box on COVID vaccines. AZ-Daiichi get FDA nod in first line breast cancer https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/2000978133793804725)  2025-12-16T17:15Z 17.5K followers, [---] engagements


"Thurs news: FDA mulls national priority vouchers for [--] potential Merck blockbusters. Novo submits NDA to FDA for CagriSema. Takeda plans psoriasis filing. Moderna scores $54M From CEPI. AbbVie and others near MFN deal. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/2001706638391034226)  2025-12-18T17:30Z 17.5K followers, [---] engagements


"Fri news: Biomarin buying rare disease drugmaker Amicus. Boehringer walks away from schizophrenia program. Alvotech and Teva eye [----] Eylea biosim launch. Biogen betting on a tech and AI overhaul. BioSecure Act passes Congress. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/2002076532106539045)  2025-12-19T18:00Z 17.5K followers, [---] engagements


"Fri news: Pfizer leads industry drug price surge. Novo gets semaglutide IP win in China. 2025s largest med tech funding rounds. Biohaven flunks phase [--] depression trial. AbbVie doubles down on trispecifics. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/2007125088643305699)  2026-01-02T16:21Z 17.5K followers, [---] engagements


"Mon news: Novo launches first GLP-1 obesity pill in the US. Insilico and Servier in $888M oncology pact. Moderna seeks global flu vaccine approvals. Incytes blood cancer therapy succeeds in late stage trial. Novo leadership shakeup. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/2008228464977924174)  2026-01-05T17:25Z 17.5K followers, [---] engagements


"Tue news: Amgen buying protein-degrading startup. Why Sanofi got an FDA rejection for its MS drug. CDC drops some vaccines from pediatric schedule. Lilly taps Nimbus for another obesity candidate. Boehringer continues kidney disease dealmaking run. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/2008586669759623666)  2026-01-06T17:09Z 17.5K followers, [---] engagements


"Fri news: Why JPM [----] will mark end of deal drought. Novartis plans new radiopharma plant. Revolution Med soars amid swirling buyout rumors. Amazon Pharmacy to offer Wegovy pill. JNJ strikes drug pricing deal with federal government. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/2009670841567698973)  2026-01-09T16:57Z 17.5K followers, [---] engagements


"Mon news: Early signals from our AI survey. Reports that Lilly is preparing a bid for Abivax. JPMHC: AbbVie buys RemeGen cancer drug. Novartis makes $1.5B+ cancer play. Nvidia and Eli Lilly are launching an AI drug discovery lab. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/2010759633888215145)  2026-01-12T17:03Z 17.5K followers, [---] engagements


"Tue news: FDA requests removal of suicide warning from GLP-1s. BMS touts pipeline confidence in pipeline at JPM. Merck sees growth through Keytruda exclusivity loss. Illumina launch to speed up AI drug discovery. Ro and Amgen to study GLP-1 access. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/cafepharma/status/2011123909232411051)  2026-01-13T17:11Z 17.5K followers, [---] engagements


"New on CP Wire: Hippocratic AI Consolidates Life Sciences Leadership with Acquisition of Grove AI and Key Executive Appointments https://www.cafepharma.com/cpwire/article/hippocratic-ai-consolidates-life-sciences-leadership-with-acquisition-of-grove-ai-and-key-executive-appointments-release/500890 https://www.cafepharma.com/cpwire/article/hippocratic-ai-consolidates-life-sciences-leadership-with-acquisition-of-grove-ai-and-key-executive-appointments-release/500890"  
[X Link](https://x.com/cafepharma/status/2011134147981389847)  2026-01-13T17:52Z 17.5K followers, [---] engagements


"Tue news: GSK buying Rapt for $2.2B for food allergy drug. Trumps new tariff threats risk upending EU trade deal. Merck-Moderna vaccine sustains melanoma risk reduction. Possible RICO case against Lilly and Takeda. The latest biopharma AI deals. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/anyuser/status/2013658302928818536)  2026-01-20T17:02Z 17.5K followers, [---] engagements


"Thurs news: Lexicon opens path to $1B opportunity. Merck and CEPI join forces against Ebola. BMS pens solid tumor pact with Janux. FDAs Feb [--] PreCheck launch date. Takeda neuro field force layoffs. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/anyuser/status/2014389016989204629)  2026-01-22T17:25Z 17.5K followers, [---] engagements


"Fri news: Sanofi Dupixent successor heads to FDA. Novos Wegovy pill launch wows. Big Pharma shops Chinese biotechs for GLP-1s. Bauschs Xifaxan successor ph III failure. US withdraws from WHO. https://bit.ly/3JeBlY5 https://bit.ly/3JeBlY5"  
[X Link](https://x.com/anyuser/status/2014757250770804985)  2026-01-23T17:48Z 17.5K followers, [---] engagements


"Bristol-Myers launches patient management programs for Sprycel patients: The Fly on the Wall Wed 08/15/12 - 11:00 am http://t.co/YxdnuHGw http://dlvr.it/212Fnd http://dlvr.it/212Fnd"  
[X Link](https://x.com/cafepharma/status/236113673582690304)  2012-08-16T14:54Z 17.5K followers, [--] engagements


"3SBio Inc. Announces Extraordinary General Meeting of Shareholders: Yahoo/PR Newswire Sun 03/24/13 - 12:15 pm http://t.co/eiGBuKhNrA http://dlvr.it/37K3ZM http://dlvr.it/37K3ZM"  
[X Link](https://x.com/cafepharma/status/315874477315608576)  2013-03-24T17:15Z 17.6K followers, [--] engagements


"Bristol-Myers says M&A would have to be good strategic fit: The Fly on the Wall Thu 07/24/14 - 11:33 am http://t.co/UvyWhT5HOd http://dlvr.it/6QCBjP http://dlvr.it/6QCBjP"  
[X Link](https://x.com/cafepharma/status/492341210132934657)  2014-07-24T16:11Z 17.5K followers, [--] engagements


"AstraZeneca May Acquire Relypsa for $46/Share; Stock Surges: Bidness ETC http://dlvr.it/D5X7YX http://dlvr.it/D5X7YX"  
[X Link](https://x.com/cafepharma/status/680047042245230592)  2015-12-24T15:27Z 17.5K followers, [--] engagements


"Pfizer Presents Data from Phase 1b Trial Investigating Utomilumab (a 4-1BB agonist) in Combination with a http://dlvr.it/LTgPLb http://dlvr.it/LTgPLb"  
[X Link](https://x.com/cafepharma/status/739239003036090369)  2016-06-04T23:34Z 17.6K followers, [--] engagements


"3SBio snaps up Therapure CDMO for $290M: BioPharma Dive http://dlvr.it/Pl9hLl http://dlvr.it/Pl9hLl"  
[X Link](https://x.com/cafepharma/status/905427133928955904)  2017-09-06T13:47Z 17.5K followers, [--] engagements


"Hanmi scraps lung cancer drug due to AstraZeneca rival reports say: Hanmi Pharm Co. Ltd. is shelving its lung cancer drug Olitabecause of the more advantageous position a rival therapy holds in the market The Korean Heraldreports. http://dlvr.it/QPXd5z http://dlvr.it/QPXd5z"  
[X Link](https://x.com/cafepharma/status/985215237715509248)  2018-04-14T17:56Z 17.6K followers, [--] engagements


"FDA Approves IND for OBI Pharma's OBI-3424 for a Ph I/II Study in AKR1C3 Solid Tumors: OBI Pharma Inc. aTaiwanbiopharma company (TPEx: 4174) today announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug http://dlvr.it/QQ4vGG http://dlvr.it/QQ4vGG"  
[X Link](https://x.com/cafepharma/status/986979724072181760)  2018-04-19T14:47Z 17.5K followers, [--] engagements


"Pfizer culls [--] experimental cancer trials and an acne drug in Q1 clear out: Pfizer has cleared out five early stage oncology drugtests from its pipeline including three tests for utomilumab as well as an acne drug. http://dlvr.it/QRWbk6 http://dlvr.it/QRWbk6"  
[X Link](https://x.com/cafepharma/status/991706499721314304)  2018-05-02T15:50Z 17.6K followers, [--] engagements


"Indivior's shares soar [--] percent after U.S. court blocks sale of rival generic: Indivior Plcs shares jumped more than [--] percent on Monday after a U.S. court blocked a rival from selling a cheaper copycat of the British drugmakers bestselling opioid http://dlvr.it/QbqmKD http://dlvr.it/QbqmKD"  
[X Link](https://x.com/cafepharma/status/1019192262327087104)  2018-07-17T12:09Z 17.6K followers, [--] engagements


"Teva Grabs Billions Gambling on Copies of Brand-Name Drugs: Bloomberg http://tinyurl.com/6m3gg8"  
[X Link](https://x.com/cafepharma/status/1032209914)  2008-12-01T13:21Z 18K followers, [--] engagements


"FDA approves two new HIV drugs from Merck: Merck & Co Inc said on Thursday the U.S. Food And Drug Administration approved two of its HIV oral drugs nearly two months ahead of schedule. http://dlvr.it/QhhfZq http://dlvr.it/QhhfZq"  
[X Link](https://x.com/cafepharma/status/1035556591741726720)  2018-08-31T15:55Z 18K followers, [--] engagements


"Lilly Licenses Chugai Pharma's Oral Diabetes Drug for $50 Million Upfront: Eli Lilly just signed a license deal with Tokyos Chugai Pharmaceutical Co. for OWL833 Chugais oral non-peptidic GLP-1 receptor agonist. It is Phase 1-ready being evaluated for http://dlvr.it/QlZ9Gk http://dlvr.it/QlZ9Gk"  
[X Link](https://x.com/cafepharma/status/1045342323322716161)  2018-09-27T16:00Z 17.6K followers, [--] engagements


"Regeneron Sanofi Win Approval for Their First Immuno-Oncology Drug: Regeneron Pharmaceuticals Inc.andSanofiwon U.S. Food and Drug Administration approval for their first immuno-oncology drug a therapy that the companies hope will jump-start their http://dlvr.it/Qln86f http://dlvr.it/Qln86f"  
[X Link](https://x.com/cafepharma/status/1046075146061172738)  2018-09-29T16:32Z 18K followers, [--] engagements


"Becton Dickinsons Q4 meets earnings expectations beats on revenue: Becton Dickinson & Co.(NYSE:BDX) today met the consensus earnings forecasts and beat revenue expectations for both its fiscal fourth-quarter and full-year results despite a Q4 swing http://dlvr.it/QqZqLg http://dlvr.it/QqZqLg"  
[X Link](https://x.com/cafepharma/status/1059818974072889344)  2018-11-06T14:45Z 18K followers, [--] engagements


"AstraZeneca makes $1B-plus in cash-and-stock deal granting Sobi US rights to RSV drug Synagis: AstraZeneca$AZNhasdivestedthe US rights to its preventative RSV drug Synagis to Swedish Orphan Biovitrum AB (Sobi) for $1.5 billion in cash and stock as http://dlvr.it/Qr8cHr http://dlvr.it/Qr8cHr"  
[X Link](https://x.com/cafepharma/status/1062396198445703169)  2018-11-13T17:26Z 17.6K followers, [--] engagements


"U.S. court allows generic version of Indivior opioid abuse drug: A U.S. appeals court on Tuesday allowed generic drug company Dr. Reddys Laboratories to sell a copycat version of the Indivior Plc opioid treatment Suboxone Film sending Indiviors stock http://dlvr.it/Qrmtcp http://dlvr.it/Qrmtcp"  
[X Link](https://x.com/cafepharma/status/1065263247069085697)  2018-11-21T15:18Z 17.6K followers, [--] engagements


"Ireland and Industry Leaders Announce $400 Million Program to Create Genomic Research Hub: * The program brings together many industry heavyweights including: WuXi NextCODE ARCH Venture Partners Polaris Partners and Sequoia Capital * The Ireland http://dlvr.it/QsK6k9 http://dlvr.it/QsK6k9"  
[X Link](https://x.com/cafepharma/status/1067799543092150272)  2018-11-28T15:17Z 17.9K followers, [--] engagements


"Indivior temporarily stops rival Alvogen's generic launch: Indivior Plc said on Friday a U.S. district court had granted the British drugmaker a temporary restraining order stopping rival Alvogen from launching cut-price versions of its blockbuster http://dlvr.it/QxXKdb http://dlvr.it/QxXKdb"  
[X Link](https://x.com/cafepharma/status/1089156009858293760)  2019-01-26T13:40Z 17.6K followers, [--] engagements


"Indivior to Sell Rights in China for $122 Million: Indivior PLC (LON: INDV) (Indivior or the Company) announced on 2/2/19 that it has entered into a definitive agreement to divest its rights related to the Sai Bo Song (buprenorphine naloxone) tablet http://dlvr.it/QyJmhn http://dlvr.it/QyJmhn"  
[X Link](https://x.com/cafepharma/status/1093159143874060289)  2019-02-06T14:47Z 17.6K followers, [--] engagements


"Incyte Down as FDA Extends Review Period of Jakafi for GVHD: Shares of Incyte Corporation INCY declined 1.9% after the FDA extended the review period of the supplemental New Drug Application (sNDA) for Jakafi to treat patients with acute http://dlvr.it/QyXqKh http://dlvr.it/QyXqKh"  
[X Link](https://x.com/cafepharma/status/1094293987454681091)  2019-02-09T17:56Z 17.6K followers, [--] engagements


"Blood Giant Grifols Acquires $1.9 Billion Stake in Shanghai RAAS: Grifols SA agreed to pay about $1.9 billion for a stake in Shanghai RAAS Blood Products Co. gaining a major foothold in Chinas booming blood-products market. http://dlvr.it/R0MsCb http://dlvr.it/R0MsCb"  
[X Link](https://x.com/cafepharma/status/1103669142626811904)  2019-03-07T14:50Z 17.6K followers, [--] engagements


"Luye submits NDA for schizophrenia bipolar disorder therapy: Luye submitted an NDA to FDA for Rykindo risperidone extended-release microspheres (LY03004) to treat schizophrenia and bipolar disorder. Luye Pharma Group Ltd. (HKSE:2186) hopes to launch the http://dlvr.it/R1sDnG http://dlvr.it/R1sDnG"  
[X Link](https://x.com/cafepharma/status/1112045080196440064)  2019-03-30T17:33Z 17.6K followers, [--] engagements


"Polaris Partners Files for New $400 Million Fund http://tinyurl.com/yygup44p http://tinyurl.com/yygup44p"  
[X Link](https://x.com/cafepharma/status/1140976423932432385)  2019-06-18T13:35Z 17.8K followers, [--] engagements


"Polaris Partners Files for New $400 Million Fund http://tinyurl.com/y4x8mvdr http://tinyurl.com/y4x8mvdr"  
[X Link](https://x.com/cafepharma/status/1140983844218265602)  2019-06-18T14:05Z 17.8K followers, [--] engagements


"Another hit for AbbVie: Unexpected $673M Irish tax bill adds to Allergan merger woes http://dlvr.it/RGKS97 http://dlvr.it/RGKS97"  
[X Link](https://x.com/cafepharma/status/1184507430962511872)  2019-10-16T16:32Z 18K followers, [--] engagements


"Merck Nycomed to jointly market COPD treatment- Marketwatch Mon 04/26/10 - 9:22 am http://is.gd/bItem"  
[X Link](https://x.com/cafepharma/status/12883894298)  2010-04-26T13:50Z 18K followers, [--] engagements


"Novo Nordisk to boost pill-form diabetic drugs with $1.8 billion deal http://dlvr.it/Rl7phB http://dlvr.it/Rl7phB"  
[X Link](https://x.com/cafepharma/status/1324750274502688769)  2020-11-06T16:27Z 17.6K followers, [--] engagements


"House committee questions Eli Lilly Sanofi and Novo Nordisk as insulin prices remain 'unacceptably high' http://dlvr.it/S61Z41 http://dlvr.it/S61Z41"  
[X Link](https://x.com/cafepharma/status/1428762639207866377)  2021-08-20T16:55Z 17.9K followers, [--] engagements


"Eisai signs agreement with Kissei Pharmaceutical for Urief: Trading Markets http://tinyurl.com/cmyc4e"  
[X Link](https://x.com/cafepharma/status/1440718205)  2009-04-02T20:27Z 17.6K followers, [--] engagements


"Carlyle's acquisition of Abingworth brings $2 billion to fuel life science investments http://dlvr.it/SNT8Bb http://dlvr.it/SNT8Bb"  
[X Link](https://x.com/cafepharma/status/1514050780885528577)  2022-04-13T01:20Z 17.9K followers, [--] engagements


"Atlas Ventures Bruce Booth on testing the IPO waters and putting the tech in biotech http://dlvr.it/SXV6zK http://dlvr.it/SXV6zK"  
[X Link](https://x.com/cafepharma/status/1564658466501070849)  2022-08-30T16:57Z 17.9K followers, [--] engagements


"AZ claims another Imjudo approval in big first-line NSCLC market Fake Eli Lilly Twitter account falsely claimed insulin 'free' Medtech execs rethink long-term strategies as care settings shift -- See more on our front page news http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1591098151729238017)  2022-11-11T15:58Z 17.9K followers, [--] engagements


"Drug Companies Stocks Underperfomed: AMGN NVO JNJ - Trader's Huddle Sat 12/18/10 - 12:44 pm http://is.gd/iZm6X"  
[X Link](https://x.com/cafepharma/status/16342528378798080)  2010-12-19T04:02Z 17.9K followers, [--] engagements


"Is Pfizer What The Doctor Ordered Or Bad Medicine: Investopedia http://tinyurl.com/camzgp"  
[X Link](https://x.com/cafepharma/status/1668046109)  2009-05-01T10:22Z 18K followers, [--] engagements


"AbbVie's Skyrizi posts ulcerative colitis win in maintenance study teeing up FDA nod This biotech is developing the next Ozempic -- On the cusp of full approval Leqembi's rollout could face challenges -- See more on our front page news http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1669731470217297921)  2023-06-16T15:39Z 18K followers, [---] engagements


"10 clinical trials to watch in the second half of [----] AstraZeneca sows $400M investment in push to plant 200M trees by [----] --What will AbbVie buy next -- See more on our front page news"  
[X Link](https://x.com/anyuser/status/1674086313148940289)  2023-06-28T16:08Z [--] followers, [---] engagements


"Roche's divarasib scores phase [--] win in KRAS-mutated solid tumors -- AbbVie removes two early-stage cancer assets from pipeline -- Vivek Ramaswamys brashness made waves in the Republican debate -- See more on our front page news"  
[X Link](https://x.com/cafepharma/status/1694741655067230310)  2023-08-24T16:01Z 18K followers, [---] engagements


"AbbVie's Humira to take hit from biosimilars next-gen therapies -- Walgreens to pay $44M to settle claims over fraudulent Theranos tests -- AstraZeneca signs AI-powered drug discovery pact with Verge -- See more on our front page news"  
[X Link](https://x.com/cafepharma/status/1700174077980234226)  2023-09-08T15:47Z 18K followers, [---] engagements


"FDA staff hold major concerns with Brainstorm ALS therapy documents show -- Daiichi Sankyo reports positive results from trial of breast cancer therapy -- AbbVie ends I-Mab partnership for CD47 antibody compounds -- See more on our front page news"  
[X Link](https://x.com/cafepharma/status/1706338820361183658)  2023-09-25T16:04Z 18K followers, [---] engagements


"AbbVie buys Parkinsons disease drugmaker Mitokinin -- Amgen completes $27.8B Horizon acquisition following FTC challenge -- Boehringer moves obesity therapy into phase [--] -- See more on our front page news"  
[X Link](https://x.com/cafepharma/status/1710323948963918184)  2023-10-06T15:59Z 18K followers, [---] engagements


"Novo Nordisk once again dials up its [----] sales and profit expectations -- Pfizer gets FDA nod for ulcerative colitis drug Velsipity -- Alnylam CEO disappointed with FDAs Onpattro rejection pivots to the future -- See more on our front page news"  
[X Link](https://x.com/cafepharma/status/1712864990883983703)  2023-10-13T16:16Z 18K followers, [---] engagements


"AbbVie trumpets Skyrizi's resounding win against J&J's Stelara in Crohn's disease -- Novo Nordisk buys rival to Bayer's kidney drug Kerendia in $1.3B deal -- AZs Tagrisso plus chemo get fast FDA review for lung cancer -- See more on our front page news"  
[X Link](https://x.com/cafepharma/status/1713960103584444512)  2023-10-16T16:48Z 18K followers, [---] engagements


"Jazz looks at strategic options including possible sale or unit divestiture-- GE HealthCare Novo Nordisk partner to treat diabetes and obesity with ultrasound --Lung cancer takes center stage at ESMO [----] with new drugs -- See more on our front page news"  
[X Link](https://x.com/cafepharma/status/1715403171973984673)  2023-10-20T16:22Z 18K followers, [---] engagements


"BIO CEO urges biotechs to be flexible on funding to survive tough times-- Amgen plans to lay off [---] former Horizon employees after $28B buyout--GSK targets younger age group with RSV vaccine Arexvy -- See more on our front page news"  
[X Link](https://x.com/cafepharma/status/1717203034290163784)  2023-10-25T15:34Z 18K followers, [---] engagements


"Lillys ulcerative colitis therapy mirikizumab finally snags FDA approval-- AbbVie stock dives as aesthetics sales mar its third quarter beat --Sanofi loses $21 bln in market value after dropping [----] profit target -- See more on our front page news"  
[X Link](https://x.com/cafepharma/status/1717938239636480036)  2023-10-27T16:16Z 18K followers, [---] engagements


"AstraZeneca's failed cancer drug gets new lease on life thanks to positive kidney disease data-- Lexeo drops share price at last minute in attempt to raise $100M IPO --Study of J&J device shows promising results for AFib -- See more on our front page news"  
[X Link](https://x.com/cafepharma/status/1720478399368466683)  2023-11-03T16:29Z 18K followers, [---] engagements


"CRISPR eyes autoimmune disease in revamp of cell therapy plans-- Johnson & Johnson forecasts as much as 6% sales growth in [----] --Eli Lilly's obesity drug now available in U.S. pharmacies"  
[X Link](https://x.com/cafepharma/status/1732084630893793282)  2023-12-05T17:08Z 18K followers, [---] engagements


"Merck KGaA's BTK inhibitor fails phase III MS studies-- Adherence to weight-loss drugs is far higher with Wegovy than older medicines --CVS drug pricing overhaul signals a broader industry shift"  
[X Link](https://x.com/cafepharma/status/1732448213804695932)  2023-12-06T17:13Z 18K followers, [---] engagements


"For Merck Lynparza fails to improve on Keytruda in first-line lung cancer-- AbbVie to buy Cerevel in $8.7B bet on brain drugs --Trial finds Lillys Olumiant could treat type [--] diabetes"  
[X Link](https://x.com/cafepharma/status/1732811541819371598)  2023-12-07T17:17Z 18K followers, [---] engagements


"Pfizer reveals reorganization executive departure as it gets ready to close $43B Seagen buyout -- AstraZeneca buys into RSV vaccine market with potential $1.1B Icosavax purchase --US diabetes patients face delays as insurers tighten Ozempic coverage"  
[X Link](https://x.com/cafepharma/status/1734611961919439023)  2023-12-12T16:31Z 18K followers, [---] engagements


"After a record run fewer biotechs are going public-- Merck Astellas and Pfizer bring down the house with Keytruda-Padcev FDA nod in bladder cancer [--] medtech trends to watch in [----] http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1737156088921723164)  2023-12-19T17:01Z 18K followers, [---] engagements


"Market for CAR-Ts still bright despite FDA cancer safety review-- Roche teaming up with Nvidia to make drugs with AI FDA accepts Mercks pneumococcal vaccine BLA for priority review"  
[X Link](https://x.com/cafepharma/status/1737519129349755391)  2023-12-20T17:03Z 18K followers, [---] engagements


"CVS to remove AbbVies Humira from reimbursement lists cover biosimilars-- Lilly launches website home delivery option for weight-loss drugs Novo Nordisk offers [--] Flagship biotechs up to $1B total for obesity MASH deals"  
[X Link](https://x.com/cafepharma/status/1742960763893899414)  2024-01-04T17:26Z 18K followers, [---] engagements


"J&J to acquire ADC drug developer Ambrx for $2B-- Merck inks $680M Harpoon buyout spearing challenger to Amgen T-cell engager Novartis dances into JPM with $250M Calypso buyout $185M RNAi alliance"  
[X Link](https://x.com/cafepharma/status/1744408103137784020)  2024-01-08T17:17Z 18K followers, [---] engagements


"VCs confident in biotech activity for [--] FDA says no evidence yet linking weight loss drugs to suicidal thoughts JPM24: Diabesity duopoly between Novo Lilly takes center stage http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1745490553188364795)  2024-01-11T16:59Z 18K followers, [---] engagements


"AbbVies Humira maintains market dominance amid biosimilar launches Bayer CEO Bill Anderson makes his mark with major restructuring 'significant' job cuts Novartis ends phase III peanut allergy trial"  
[X Link](https://x.com/cafepharma/status/1748022865583124906)  2024-01-18T16:41Z 18K followers, [---] engagements


"Saudi Arabia launches plan to become biotech hub by [----] FDA reveals more details on [--] CAR-T secondary cancer cases Merck finds drug discovery DALL-E becoming early user of small molecule generative AI"  
[X Link](https://x.com/cafepharma/status/1750561191947030886)  2024-01-25T16:48Z 18K followers, [---] engagements


"After Padcev combos major triumph Mercks Keytruda delivers partial win in bladder cancer ArriVent takes in $175M from second biotech IPO of the year No decision yet on Wegovy heart benefits from EU drug"  
[X Link](https://x.com/cafepharma/status/1750932361703723064)  2024-01-26T17:23Z 18K followers, [---] engagements


"BMS more likely to bet on bolt-ons after recent buying spreeAs Humira plummets AbbVie dials up Rinvoq and Skyrizi estimates to a combined $27B Brain drug developer Alto Neuroscience prices $129M"  
[X Link](https://x.com/cafepharma/status/1753473629046575290)  2024-02-02T17:41Z 18K followers, [---] engagements


"Lilly expects strong [----] profit on rising weight-loss drug demandSanofi guarantees employees one year of salary and support after cancer diagnosis GSKs Blenrep combo scores phase III win in multiple"  
[X Link](https://x.com/cafepharma/status/1754890231713513734)  2024-02-06T15:30Z 18K followers, [---] engagements


"AbbVie CEO Richard Gonzalez to step down Robert Michael to succeed him Medtronic lifts annual profit forecast exits ventilator businessFDA approves Iovance's Amtagvi as first T-cell therapy for a solid tumor--for more news:"  
[X Link](https://x.com/cafepharma/status/1759982912655569266)  2024-02-20T16:46Z 18K followers, [---] engagements


"Moderna posts surprise quarterly profit as it eyes RSV vaccine approval Samsung joins biosimilar race for Merck & Co.'s Keytruda blockbusterZimmer receives FDA clearance for robotic shoulder system-- more news: http://bit.ly/w28kSd http://bit.ly/w28kSd"  
[X Link](https://x.com/cafepharma/status/1760710064178909339)  2024-02-22T16:56Z 18K followers, [---] engagements


"AbbVie puts potential $713M on the line for OSEs inflammation antibodyEli Lilly could launch obesity drug in India next year CEO saysAfter steep cost cuts Novavax's fourth-quarter performance falls short of expectations-- more news:"  
[X Link](https://x.com/cafepharma/status/1762878888387006500)  2024-02-28T16:34Z 18K followers, [---] engagements


"Eisai Rises as Company Says It Can End Pfizer Pact: Bloomberg http://tinyurl.com/qfv3un"  
[X Link](https://x.com/cafepharma/status/1763101202)  2009-05-11T13:47Z 18K followers, [--] engagements


"Novo kidney trial finds Ozempic cuts cardiac risks in diabeticsBayer CEO launches full-scale effort to rejuvenate pharma pipeline tables split-up but warns not neverRoche Alnylam say blood pressure drug succeeds in mid-stage trial-- more news:"  
[X Link](https://x.com/cafepharma/status/1765061759663301058)  2024-03-05T17:08Z 18K followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing